Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Phytosterols may help manage prostate issues but are less effective than synthetic drugs.

Adalimumab improved folliculitis decalvans in most patients.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

Pranlukast and mirabegron may work as new diabetes drugs.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Clascoterone may be an effective topical treatment for hair loss.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

17β-estradiol may help hair growth by increasing cannabinoid receptor type 1.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Cosmos caudatus extract is as effective as finasteride for treating benign prostatic hyperplasia without its side effects.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

5-alpha reductase inhibitors do not increase hip fracture risk.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Cedrol may help treat rheumatoid arthritis due to its anti-inflammatory and antioxidant effects.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.